Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study

Authors:

Abstract
No abstract available

This publication has 28 references indexed in Scilit: